Guidelines Updated for Reducing Hypoglycemia Risk in Diabetes
Strong recommendations include use of glucagon preparations that do not need reconstitution, real-time CGM for those receiving multiple daily injections
Stay updated with breaking news from Anthonyl Mccall. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Strong recommendations include use of glucagon preparations that do not need reconstitution, real-time CGM for those receiving multiple daily injections
FRIDAY, Dec. 30, 2022 (HealthDay News) -- Advances in medications and technology should be leveraged to reduce the risk for hypoglycemia for people with diabetes, according to a clinical practice guideline issued by the Endocrine Society and published online Dec. 7 in the Journal of Clinical Endocrinology & Metabolism. Anthony L. McCall, M.D., Ph.D., from
The latest guideline from The Endocrine Society updates recommendations to reflect new treatment options for hypoglycemia prevention and treatment in diabetes.
Endocrine Society Clinical Practice Guideline examines better ways to manage hypoglycemia in people with diabetes.
People with diabetes are benefiting from advances in medications and technologies to lower their risk of hypoglycemia, according to a Clinical Practice Guideline issued today by the Endocrine Society.